Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.12
+2.40 (5.25%)
At close: May 20, 2026, 4:00 PM EDT
48.25
+0.13 (0.27%)
Pre-market: May 21, 2026, 4:11 AM EDT
Moderna Revenue
Moderna had revenue of $389.00M in the quarter ending March 31, 2026, with 260.19% growth. This brings the company's revenue in the last twelve months to $2.23B, down -29.97% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%.
Revenue (ttm)
$2.23B
Revenue Growth
-29.97%
P/S Ratio
8.58
Revenue / Employee
$473,404
Employees
4,700
Market Cap
19.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | -1.29B | -39.93% |
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Incyte | 5.36B |
| Jazz Pharmaceuticals | 4.44B |
| Genmab | 3.90B |
| BioNTech SE | 3.23B |
| Royalty Pharma | 2.44B |
| Exelixis | 2.38B |
| Ascendis Pharma | 998.25M |
| Insmed | 819.56M |
MRNA News
- 1 day ago - Mixed options sentiment in Moderna with shares down 3.48% - TheFly
- 1 day ago - Moderna Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Moderna Recognized by TIME as One of the World's Most Impactful Companies - Accesswire
- 8 days ago - Moderna Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Moderna's AI Could Get a Hantavirus Vaccine Here Faster - PYMNTS
- 9 days ago - Hantavirus outbreak: these 3 stocks are poised to rip higher - Invezz
- 9 days ago - Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. - Investopedia
- 9 days ago - Early notable gainers among liquid option names on May 11th - TheFly